tifaxin sr 75 mg prolonged - release capsules, hard
stada arzneimittel ag - Венлафаксин - 75 mg prolonged - release capsules, hard
tifaxin sr 150 mg prolonged - release capsules, hard
stada arzneimittel ag - Венлафаксин - 150 mg prolonged - release capsules, hard
tifaxin spm 75 mg prolonged - release capsules, hard
75 mg prolonged - release capsules, hard
tifaxin spm 150 mg prolonged - release capsules, hard
150 mg prolonged - release capsules, hard
orfadin
swedish orphan biovitrum international ab - нитисинона - tyrosinemias - Други стомашно-чревния тракт и обмяната на веществата средства, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).
tifaxin sr 37,5 mg prolonged - release capsules, hard
stada arzneimittel ag - Венлафаксин - 37,5 mg prolonged - release capsules, hard
riodin 15 mg tablets
stada arzneimittel ag - Пиоглитазон - 15 mg tablets
riodin 30 mg tablets
stada arzneimittel ag - Пиоглитазон - 30 mg tablets
riodin 45 mg tablets
stada arzneimittel ag - Пиоглитазон - 45 mg tablets
jimandin 100 mg film - coated tablets
100 mg film - coated tablets